EVIDENT Expands Its Pramana Digital Pathology Portfolio to Support Small and Medium-Sized Labs
October 17, 2026

Asia's first dedicated B2B Pre-Owned Mobile Devices focus...

MACAO, Oct. 17, 2026 /PRNewswire/ -- The 12th...

Prince Abdulaziz bin Talal credits the founders of...

DEEp SEA is a global Phase III trial evaluating efficacy, safety and...

First FDA-approved stent designed specifically for the smallest patients with certain congenital...

Anti-B7-H3 antibody-drug conjugate reduced the risk of death by 54% versus topotecan...

Ribbon-cutting held on World Suicide Prevention DayRED BANK, N.J., Sept. 12, 2026...






